Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine
- PMID: 2172456
- DOI: 10.1099/0022-1317-71-10-2425
Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine
Abstract
The gene encoding the pseudorabies virus glycoprotein gp50 was cloned at the very left end of the genome of adenovirus type 5 to give a recombinant adenovirus (Ad-gp50) defective for the E1A gene. Ad-gp50 expressed high levels of gp50 in cells which either complemented (293 cells) or did not complement (Vero and HeLa cells) the E1A gene. Surprisingly, over an extended period, higher levels of gp50 were produced in HeLa cells which lack the E1A gene. Rabbits and mice inoculated with Ad-gp50 showed a strong antibody response against gp50. Some of them were protected from a virulent challenge with pseudorabies virus.
Similar articles
-
Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.J Gen Virol. 1995 Jul;76 ( Pt 7):1583-9. doi: 10.1099/0022-1317-76-7-1583. J Gen Virol. 1995. PMID: 9049365
-
Enhancement of the efficacy of a replication-defective adenovirus-vectored vaccine by the addition of oil adjuvants.Vaccine. 1994 Oct;12(13):1190-6. doi: 10.1016/0264-410x(94)90242-9. Vaccine. 1994. PMID: 7839723
-
Comparison of the protective response induced by NYVAC vaccinia recombinants expressing either gp50 or gII and gp50 of pseudorabies virus.Can J Vet Res. 1996 Oct;60(4):315-7. Can J Vet Res. 1996. PMID: 8904669 Free PMC article.
-
Non-transmissible pseudorabies virus gp50 mutants: a new generation of safe live vaccines.Vaccine. 1994 Mar;12(4):375-80. doi: 10.1016/0264-410x(94)90104-x. Vaccine. 1994. PMID: 8178562
-
Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine.J Virol. 1993 Mar;67(3):1529-37. doi: 10.1128/JVI.67.3.1529-1537.1993. J Virol. 1993. PMID: 8382308 Free PMC article.
Cited by
-
Packaging capacity and stability of human adenovirus type 5 vectors.J Virol. 1993 Oct;67(10):5911-21. doi: 10.1128/JVI.67.10.5911-5921.1993. J Virol. 1993. PMID: 8371349 Free PMC article.
-
Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.Int Rev Neurobiol. 2003;55:3-64. doi: 10.1016/s0074-7742(03)01001-8. Int Rev Neurobiol. 2003. PMID: 12968530 Free PMC article. Review. No abstract available.
-
Foot-and-mouth disease.Clin Microbiol Rev. 2004 Apr;17(2):465-93. doi: 10.1128/CMR.17.2.465-493.2004. Clin Microbiol Rev. 2004. PMID: 15084510 Free PMC article. Review.
-
Adenovirus-based vaccines-a platform for pandemic preparedness against emerging viral pathogens.Mol Ther. 2022 May 4;30(5):1822-1849. doi: 10.1016/j.ymthe.2022.01.034. Epub 2022 Jan 31. Mol Ther. 2022. PMID: 35092844 Free PMC article. Review.
-
Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection.Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6994-8. doi: 10.1073/pnas.96.12.6994. Proc Natl Acad Sci U S A. 1999. PMID: 10359827 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials